231 related articles for article (PubMed ID: 16447748)
1. [Abeta vaccine therapy for Alzheimer's disease].
Hara H
Rinsho Shinkeigaku; 2005 Nov; 45(11):867-9. PubMed ID: 16447748
[TBL] [Abstract][Full Text] [Related]
2. [Vaccination therapy for Alzheimer's disease].
Tabira T
Brain Nerve; 2007 Apr; 59(4):375-82. PubMed ID: 17447524
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccine therapy for Alzheimer's disease--recent progress and our approach].
Okura Y; Matsumoto Y
Brain Nerve; 2008 Aug; 60(8):931-40. PubMed ID: 18717197
[TBL] [Abstract][Full Text] [Related]
4. Neuropathology after active Abeta42 immunotherapy: implications for Alzheimer's disease pathogenesis.
Boche D; Denham N; Holmes C; Nicoll JA
Acta Neuropathol; 2010 Sep; 120(3):369-84. PubMed ID: 20632020
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of Alzheimer disease: A beta vaccine].
Tabira T; Hara H
Rinsho Shinkeigaku; 2004 Nov; 44(11):778-80. PubMed ID: 15651289
[TBL] [Abstract][Full Text] [Related]
6. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.
Boche D; Zotova E; Weller RO; Love S; Neal JW; Pickering RM; Wilkinson D; Holmes C; Nicoll JA
Brain; 2008 Dec; 131(Pt 12):3299-310. PubMed ID: 18953056
[TBL] [Abstract][Full Text] [Related]
7. Reduction of amyloid beta-peptide accumulation in Tg2576 transgenic mice by oral vaccination.
Ishii-Katsuno R; Nakajima A; Katsuno T; Nojima J; Futai E; Sasagawa N; Yoshida T; Watanabe Y; Ishiura S
Biochem Biophys Res Commun; 2010 Sep; 399(4):593-9. PubMed ID: 20682291
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy as treatment for Alzheimer's disease.
Hawkes CA; McLaurin J
Expert Rev Neurother; 2007 Nov; 7(11):1535-48. PubMed ID: 17997702
[TBL] [Abstract][Full Text] [Related]
9. Neurobiology. Untangling Alzheimer's by paring plaques bolsters amyloid theory.
Beckman M
Science; 2004 Aug; 305(5685):762. PubMed ID: 15297635
[No Abstract] [Full Text] [Related]
10. [Mucosal immunotherapy for alzheimer's disease with viral vectors].
Hara H; Inoue M; Adachi K; Yonemitsu Y; Hasegawa M; Nabeshima T; Tabira T
Nihon Shinkei Seishin Yakurigaku Zasshi; 2007 Apr; 27(2):53-6. PubMed ID: 17515110
[TBL] [Abstract][Full Text] [Related]
11. Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.
Okura Y; Miyakoshi A; Kohyama K; Park IK; Staufenbiel M; Matsumoto Y
Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9619-24. PubMed ID: 16769900
[TBL] [Abstract][Full Text] [Related]
12. Development of anti-Abeta vaccination as a promising therapy for Alzheimer's disease.
Okura Y; Matsumoto Y
Drug News Perspect; 2007; 20(6):379-86. PubMed ID: 17925892
[TBL] [Abstract][Full Text] [Related]
13. Lessons from the AN 1792 Alzheimer vaccine: lest we forget.
Robinson SR; Bishop GM; Lee HG; Münch G
Neurobiol Aging; 2004; 25(5):609-15. PubMed ID: 15172738
[TBL] [Abstract][Full Text] [Related]
14. Anti-Abeta: The good, the bad, and the unforeseen.
Broytman O; Malter JS
J Neurosci Res; 2004 Feb; 75(3):301-6. PubMed ID: 14743443
[TBL] [Abstract][Full Text] [Related]
15. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
[TBL] [Abstract][Full Text] [Related]
16. [Abeta vaccination and treatment of Alzheimer's disease].
Takeda K; Hara H
No To Shinkei; 2005 Oct; 57(10):867-76. PubMed ID: 16277231
[No Abstract] [Full Text] [Related]
17. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
Matsuda J; Kaminaka K; Nozaki C
Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
[TBL] [Abstract][Full Text] [Related]
18. [Perspectives in immunotherapy of Alzheimer's disease].
Rossi G
Recenti Prog Med; 2003; 94(7-8):305-8. PubMed ID: 12868235
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of Alzheimer's disease (AD): from murine models to anti-amyloid beta (Abeta) human monoclonal antibodies.
Geylis V; Steinitz M
Autoimmun Rev; 2006 Jan; 5(1):33-9. PubMed ID: 16338209
[TBL] [Abstract][Full Text] [Related]
20. Evidence supporting a role for anti-Abeta antibodies in the treatment of Alzheimer's disease.
Morgan D; Gitter BD
Neurobiol Aging; 2004; 25(5):605-8. PubMed ID: 15172737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]